ForSight Vision2 Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $42M

ForSight Vision2 General Information

Description

Developer of an implantable drug delivery device. The company provides ocular punctal plug delivery systems.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 199 Jefferso Dr
  • Menlo Park, CA 94025
  • United States
Primary Industry
Drug Delivery
Acquirer
Novelion Therapeutics
Corporate Office
  • 199 Jefferso Dr
  • Menlo Park, CA 94025
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ForSight Vision2 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 18-Oct-2007 $42M Completed Product Development
3. Early Stage VC (Series A) 01-Dec-2006 Completed Product Development
2. Accelerator/Incubator Completed Product Development
1. Early Stage VC Completed Product Development
To view ForSight Vision2’s complete valuation and funding history, request access »

ForSight Vision2 Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

ForSight Vision2 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-7998497-B2 Nasolacrimal drainage system implants for drug therapy Active 31-Mar-2006
US-20070269487-A1 Drug delivery methods, structures, and compositions for nasolacrimal system Active 31-Mar-2006
US-20070243230-A1 Nasolacrimal drainage system implants for drug therapy Active 31-Mar-2006
US-20130101658-A1 Drug delivery methods, structures, and compositions for nasolacrimal system Active 31-Mar-2006
US-20090092654-A1 Drug delivery methods, structures, and compositions for nasolacrimal system Inactive 31-Mar-2006 A61K9/0051
To view ForSight Vision2’s complete patent history, request access »

ForSight Vision2 Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Morgenthaler Ventures Venture Capital Minority
Split Rock Partners Venture Capital Minority
The Foundry VC-Backed Company Minority
Versant Ventures Venture Capital Minority
To view ForSight Vision2’s complete investors history, request access »

Ready to get started?

Request a free trial

ForSight Vision2 FAQs

  • When was ForSight Vision2 founded?

    ForSight Vision2 was founded in 2006.

  • Where is ForSight Vision2 headquartered?

    ForSight Vision2 is headquartered in Menlo Park, CA.

  • What industry is ForSight Vision2 in?

    ForSight Vision2’s primary industry is Drug Delivery.

  • Is ForSight Vision2 a private or public company?

    ForSight Vision2 is a Private company.

  • What is the current valuation of ForSight Vision2?

    The current valuation of ForSight Vision2 is .

  • What is ForSight Vision2’s current revenue?

    The current revenue for ForSight Vision2 is .

  • How much funding has ForSight Vision2 raised over time?

    ForSight Vision2 has raised $5M.

  • Who are ForSight Vision2’s investors?

    Morgenthaler Ventures, Split Rock Partners, The Foundry, and Versant Ventures have invested in ForSight Vision2.

  • When was ForSight Vision2 acquired?

    ForSight Vision2 was acquired on 18-Oct-2007.

  • Who acquired ForSight Vision2?

    ForSight Vision2 was acquired by Novelion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »